相关实验视频

Updated: May 23, 2025

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

巩固性放射治疗在寡头转移性和寡头进展性NSCLC:一个系统的审查

Nazmul Hasan¹, Omid Yazdanpanah², Jeremy P Harris³

¹University of California, Irvine, Department of Medicine, Orange, CA, United States.

Critical reviews in oncology/hematology

|March 10, 2025

概括

巩固性辐射疗法可能有利于非小细胞肺癌 (NSCLC) 的选定患者,这种癌症已经传播最小或进展缓慢. 适当的患者选择是改善诸如无进展生存率等结果的关键.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
医学物理医学物理

背景情况:

不小细胞肺癌 (NSCLC) 代表了一个不同的临床场景.
巩固性辐射疗法正在成为这些患者有前途的治疗方式.

研究的目的:

系统地审查关于巩固性辐射对NSCLC结果的影响的临床证据.
分析整合性放射治疗与全身疗法和生物标志物的整合.

主要方法:

临床研究的系统文献综述.
对放射治疗创新 (SBRT,IMRT) 的分析.
综合模式治疗和生物标志物应用 (ctDNA) 的评估.

主要成果:

巩固性放射治疗对特定的NSCLC患者具有潜在的益处,这些患者在系统后治疗控制的寡基质转移性疾病.
先进的放射疗法技术可以在寡头转移的环境中改善局部控制.
生物标志物对于识别合适的候选人至关重要.

结论:

巩固性辐射可以改善选择的NSCLC患者的无进展和整体存活率.
患者的选择对于成功的强化放射治疗至关重要.
需要进一步的研究来优化治疗策略和生物标志物.

关键词:

强化疗法是一种强化疗法.非小细胞肺癌是非小细胞肺癌.有氧基质扩散症 (Oligometastasis)寡头进步的发展在 SABR 中, SABR 是一款 SABR 车型.在SBRT和SBRT之间.

更多相关视频

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Stereotactic Radiosurgery for Gynecologic Cancer

Stereotactic Radiosurgery for Gynecologic Cancer

Published on: April 17, 2012

相关概念视频

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...